Serum anti-Müllerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve
- 14 July 2010
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (7) , 2846-2849
- https://doi.org/10.1016/j.fertnstert.2010.06.010
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized studyFertility and Sterility, 2010
- Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancerFertility and Sterility, 2009
- Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levelsFertility and Sterility, 2009
- Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserveFertility and Sterility, 2008
- A comparison of follicular response of ovaries to ovulation induction after laparoscopic ovarian cystectomy or fenestration and coagulation versus normal ovaries in patients with endometriomaFertility and Sterility, 2007
- Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significanceFertility and Sterility, 2007
- A systematic review of tests predicting ovarian reserve and IVF outcomeHuman Reproduction Update, 2006
- Should endometriomas be treated before IVF–ICSI cycles?Human Reproduction Update, 2005
- A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomasPublished by Elsevier ,2004
- Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysisFertility and Sterility, 2003